Health Information Management

Healthcare News: CMS changes status indicators for 10 codes

JustCoding News: Outpatient, June 27, 2012

Want to receive articles like this one in your inbox? Subscribe to JustCoding News: Outpatient!

CMS reassigned 10 codes to status indicator K (paid under OPPS; separate APC payment) as part of the July update to the Integrated Outpatient Code Editor.

The following two codes will have a status indicator K effective July 1:
  • J1680, injection, human fibrinogen concentrate, 100 mg
  • J9001, injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
CMS reassigned the following eight codes to status indicator K effective April 1:
  • 90581, anthrax vaccine, for subcutaneous or intramuscular use
  • J2265, injection, minocycline hydrochloride, 1 mg
  • J8650, nabilone, oral, 1 mg
  • Q0174, thiethylperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
  • Q4123, AlloSkin™ RT, per square centimeter
  • Q4125, ArthroFlex™, per square centimeter
  • Q4128, FlexHD® or AlloPatch HD™, per square centimeter
  • Q4129, Unite® Biomatrix, per square centimeter
 
All 10 codes previously fell under status indicator E (not paid by Medicare when submitted on outpatient claims [any outpatient bill type]).



Want to receive articles like this one in your inbox? Subscribe to JustCoding News: Outpatient!

Most Popular